News

A preclinical study reports that targeting an enzyme with a crucial role in protein synthesis improves hypersensitivity in rodent models of migraine. The strategy has promising therapeutic potential to treat migraine in people.

A consensus panel of the European Headache Federation provides definitions of triptan responders and non-responders. The effort could improve migraine treatment and standardize research.

A recent proof-of-concept study shows that natural language processing and machine learning can accurately classify migraine versus cluster headache.

A new study further advances the case that the drug suppresses central sensitization, acting only in the trigeminal nociceptive system.

A new study provides the first population-based estimate of the incidence of status migrainosus.

A new study examines pain prevalence in Black, White, Hispanic, Asian, multiracial and Native American adults in the United States. The work finds that differences between Black and White groups pale in comparison to differences between other racial/ethnic groups.

A new study finds that higher vascular risk scores are associated with lower chances of active or incident migraine.

A new replication and extension study finds little to connect the trait of mindfulness with pain in healthy controls, nor is it associated with improvements in headache in people with migraine.

“Episodic” versus “chronic” migraine is not a biologically meaningful distinction, according to a new fMRI study.

The new approach accurately detects squinting in response to CGRP and amylin, and proves superior to a manual strategy.